STRATA Skin Sciences, Inc. (SSKN)
USD 3.0
(-1.64%)
USD 3.0
(-1.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 15.63 Million USD | 85.2% |
| 2022 | 8.44 Million USD | 5.13% |
| 2021 | 8.02 Million USD | -26.22% |
| 2020 | 10.88 Million USD | 25.57% |
| 2019 | 8.66 Million USD | 17.16% |
| 2018 | 7.39 Million USD | -30.2% |
| 2017 | 10.59 Million USD | -55.54% |
| 2016 | 23.83 Million USD | 11.99% |
| 2015 | 21.28 Million USD | 325.55% |
| 2014 | 5 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 60 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 16.51 Million USD | -0.19% |
| 2024 Q1 | 16.54 Million USD | 5.81% |
| 2023 FY | 15.63 Million USD | 85.2% |
| 2023 Q1 | 8.38 Million USD | -0.64% |
| 2023 Q3 | 15.7 Million USD | -0.41% |
| 2023 Q2 | 15.76 Million USD | 87.98% |
| 2023 Q4 | 15.63 Million USD | -0.44% |
| 2022 Q4 | 8.44 Million USD | 1.03% |
| 2022 Q3 | 8.35 Million USD | 5.65% |
| 2022 FY | 8.44 Million USD | 5.13% |
| 2022 Q1 | 7.96 Million USD | -0.75% |
| 2022 Q2 | 7.9 Million USD | -0.77% |
| 2021 Q4 | 8.02 Million USD | -0.7% |
| 2021 Q1 | 10.79 Million USD | -0.84% |
| 2021 Q2 | 8.67 Million USD | -19.65% |
| 2021 Q3 | 8.08 Million USD | -6.75% |
| 2021 FY | 8.02 Million USD | -26.22% |
| 2020 Q4 | 10.88 Million USD | -0.78% |
| 2020 Q3 | 10.96 Million USD | -0.76% |
| 2020 Q2 | 11.05 Million USD | 28.42% |
| 2020 Q1 | 8.6 Million USD | -0.69% |
| 2020 FY | 10.88 Million USD | 25.57% |
| 2019 Q1 | 8.2 Million USD | 10.9% |
| 2019 Q3 | 8.91 Million USD | -0.61% |
| 2019 Q4 | 8.66 Million USD | -2.81% |
| 2019 FY | 8.66 Million USD | 17.16% |
| 2019 Q2 | 8.97 Million USD | 9.37% |
| 2018 Q2 | 7.37 Million USD | -30.0% |
| 2018 Q1 | 10.53 Million USD | -0.62% |
| 2018 Q4 | 7.39 Million USD | 0.48% |
| 2018 FY | 7.39 Million USD | -30.2% |
| 2018 Q3 | 7.36 Million USD | -0.14% |
| 2017 FY | 10.59 Million USD | -55.54% |
| 2017 Q1 | 24.45 Million USD | 2.6% |
| 2017 Q2 | 25.1 Million USD | 2.65% |
| 2017 Q3 | 10.81 Million USD | -56.93% |
| 2017 Q4 | 10.59 Million USD | -1.99% |
| 2016 FY | 23.83 Million USD | 11.99% |
| 2016 Q4 | 23.83 Million USD | 4.51% |
| 2016 Q3 | 22.8 Million USD | 2.43% |
| 2016 Q2 | 22.26 Million USD | 1.9% |
| 2016 Q1 | 21.84 Million USD | 2.65% |
| 2015 Q4 | 21.28 Million USD | 5.04% |
| 2015 Q3 | 20.26 Million USD | 14.78% |
| 2015 Q2 | 17.65 Million USD | 274.96% |
| 2015 Q1 | 4.7 Million USD | -5.87% |
| 2015 FY | 21.28 Million USD | 325.55% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | 5 Million USD | -0.62% |
| 2014 Q3 | 5.03 Million USD | 0.0% |
| 2014 FY | 5 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | 5.36 Million USD | 1.44% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | -100.0% |
| 2013 Q1 | 5.28 Million USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | 60 Thousand USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 97.114% |
| Nemaura Medical Inc. | 20.03 Million USD | 21.953% |
| NeuroPace, Inc. | 72.39 Million USD | 78.406% |
| LENSAR, Inc. | 2.3 Million USD | -577.046% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -112.81% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -880.125% |
| Apyx Medical Corporation | 38.5 Million USD | 59.396% |
| Cutera, Inc. | 431.91 Million USD | 96.381% |
| BioSig Technologies, Inc. | 452 Thousand USD | -3358.628% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 60.14% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.07% |
| Axonics, Inc. | 27.61 Million USD | 43.394% |
| IRIDEX Corporation | 2.74 Million USD | -469.301% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 80.262% |
| TELA Bio, Inc. | 42.78 Million USD | 63.457% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -4136.585% |
| RxSight, Inc. | 3.01 Million USD | -419.024% |
| Align Technology, Inc. | 96.96 Million USD | 83.878% |
| INVO Bioscience, Inc. | 8.68 Million USD | -80.03% |
| electroCore, Inc. | 626 Thousand USD | -2397.284% |
| Telesis Bio, Inc. | 34.38 Million USD | 54.529% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -52.203% |
| Quipt Home Medical Corp. | 98.94 Million USD | 84.2% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 46.162% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -565.801% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -2.478% |
| Dynatronics Corporation | 6.68 Million USD | -133.749% |
| Modular Medical, Inc. | 1.19 Million USD | -1213.697% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -5866.794% |
| Talis Biomedical Corporation | 19.66 Million USD | 20.516% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -1045.241% |
| InMode Ltd. | 9.01 Million USD | -73.373% |
| Envoy Medical, Inc. | 404 Thousand USD | -3769.554% |
| Bruker Corporation | 1.37 Billion USD | 98.867% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -27326.316% |
| DexCom, Inc. | 2.59 Billion USD | 99.397% |
| Nexalin Technology, Inc. | 4463.00 USD | -350180.081% |
| PAVmed Inc | 48.72 Million USD | 67.916% |
| Viveve Medical, Inc. | 5.34 Million USD | -192.26% |
| Cerus Corporation | 95.99 Million USD | 83.715% |
| Movano Inc. | 252 Thousand USD | -6103.571% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 52.876% |
| Nexalin Technology, Inc. | 4463.00 USD | -350180.081% |
| IceCure Medical Ltd | 599 Thousand USD | -2509.85% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 96.239% |
| enVVeno Medical Corporation | 1.4 Million USD | -1015.05% |
| 908 Devices Inc. | 5.94 Million USD | -162.96% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -12.137% |
| Orthofix Medical Inc. | 134.19 Million USD | 88.351% |
| Surmodics, Inc. | 29.4 Million USD | 46.836% |
| Nuwellis, Inc. | 981 Thousand USD | -1493.578% |
| Outset Medical, Inc. | 136.18 Million USD | 88.521% |
| Venus Concept Inc. | 79.69 Million USD | 80.384% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 87.958% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 77.763% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -86.196% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -1562.526% |
| Inogen, Inc. | 21.92 Million USD | 28.691% |
| IRadimed Corporation | 2.04 Million USD | -665.182% |
| MaxCyte, Inc. | 18.74 Million USD | 16.593% |
| Pulmonx Corporation | 41.42 Million USD | 62.261% |
| PAVmed Inc. | 48.72 Million USD | 67.916% |
| iCAD, Inc. | 461 Thousand USD | -3291.106% |
| OrthoPediatrics Corp. | 23.76 Million USD | 34.205% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -683.02% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -3077.497% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -8377.766% |
| SI-BONE, Inc. | 38.99 Million USD | 59.907% |
| Semler Scientific, Inc. | 70 Thousand USD | -22232.857% |
| Beyond Air, Inc. | 17.83 Million USD | 12.356% |
| FONAR Corporation | 41.67 Million USD | 62.489% |
| AxoGen, Inc. | 69.29 Million USD | 77.439% |
| Biotricity, Inc. | 23.87 Million USD | 34.532% |
| Cytosorbents Corporation | 18.31 Million USD | 14.635% |
| ZimVie Inc. | 521.92 Million USD | 97.005% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 68.967% |
| Inari Medical, Inc. | 32.04 Million USD | 51.219% |
| UFP Technologies, Inc. | 46.03 Million USD | 66.043% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -683.02% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -409.042% |
| Sight Sciences, Inc. | 35.41 Million USD | 55.856% |
| Insulet Corporation | 1.44 Billion USD | 98.921% |
| Profound Medical Corp. | 7.9 Million USD | -97.877% |
| Bioventus Inc. | 409.47 Million USD | 96.182% |
| InspireMD, Inc. | 1.59 Million USD | -880.125% |
| BrainsWay Ltd. | 471 Thousand USD | -3219.108% |
| BIOLASE, Inc. | 17.91 Million USD | 12.714% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -1408.485% |
| Tenon Medical, Inc. | 1.17 Million USD | -1232.737% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1460.18% |
| CVRx, Inc. | 30.61 Million USD | 48.933% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.319% |
| Sintx Technologies, Inc. | 4.24 Million USD | -268.269% |
| Acutus Medical, Inc. | 38.47 Million USD | 59.373% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -683.609% |
| NanoVibronix, Inc. | 5000.00 USD | -312560.0% |
| Quanterix Corporation | 41.46 Million USD | 62.297% |
| LivaNova PLC | 640.4 Million USD | 97.559% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -422.744% |
| Varex Imaging Corporation | 469.5 Million USD | 96.67% |
| Vivani Medical, Inc. | 20.69 Million USD | 24.464% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -565.801% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -1896.552% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 98.326% |
| TransMedics Group, Inc. | 515.94 Million USD | 96.97% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -721.492% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -6390.061% |
| Spectral AI, Inc. | 1.28 Million USD | -1112.801% |
| Hyperfine, Inc. | 185 Thousand USD | -8350.27% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 91.867% |
| Biomerica, Inc. | 785 Thousand USD | -1891.465% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3377.996% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -4123.936% |
| Silk Road Medical, Inc | 84.63 Million USD | 81.528% |